Results 201 to 210 of about 62,432 (254)
Some of the next articles are maybe not open access.
Archives of Pediatrics & Adolescent Medicine, 1984
Sir .—It was with a mixture of interest and personal chagrin that I read the article by Larter et al 1 on polymyxin B sulfate and pertussis vaccine—interest because I have been a sometime advocate of this particular application of the endotoxin-inactivating activity of polymyxin B, but chagrin that, in this narrow field, reference to my own publication
openaire +2 more sources
Sir .—It was with a mixture of interest and personal chagrin that I read the article by Larter et al 1 on polymyxin B sulfate and pertussis vaccine—interest because I have been a sometime advocate of this particular application of the endotoxin-inactivating activity of polymyxin B, but chagrin that, in this narrow field, reference to my own publication
openaire +2 more sources
Peptide Antibiotics (Polymyxin B and Polymyxin E)
1978Of the five polymyxins, A, B, C, D and E, originally isolated from a spore-bearing bacillus called variously B. aerosporus and B. polymyxa (Garrod et al., 1973), only two have found clinical usefulness, namely polymyxin B, usually in the form of the sulphate, and polymyxin E (colistin), either as the sulphate or sodium sulphomethate.
A. P. Ball, J. A. Gray, J. McM. Murdoch
openaire +1 more source
Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin
International Journal of Antimicrobial AgentsNephrotoxicity is the most serious and common adverse effect that limits the use of polymyxins. This study compared polymyxin E (colistin) and polymyxin B regarding drug-related nephrotoxicity.This study was conducted as a retrospective cohort study in a university hospital between January 2020 and July 2022.
Fatma Nisa Ballı +8 more
openaire +3 more sources
Biomedical Chromatography
AbstractTo facilitate clinical therapeutic drug monitoring (TDM) of polymyxin B (PB) and polymyxin E (PE), we developed and validated a simple LC–MS/MS method for simultaneous determination of PB (including polymyxin B1 (PB1), polymyxin B2 (PB2), polymyxin B3 (PB3) and isoleucine‐polymyxin B1 (ile‐PB1)) and PE (including polymyxin E1 (PE1) and ...
Feng Chen +6 more
openaire +2 more sources
AbstractTo facilitate clinical therapeutic drug monitoring (TDM) of polymyxin B (PB) and polymyxin E (PE), we developed and validated a simple LC–MS/MS method for simultaneous determination of PB (including polymyxin B1 (PB1), polymyxin B2 (PB2), polymyxin B3 (PB3) and isoleucine‐polymyxin B1 (ile‐PB1)) and PE (including polymyxin E1 (PE1) and ...
Feng Chen +6 more
openaire +2 more sources

